How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.

Slides:



Advertisements
Similar presentations
You have been given a mission and a code. Use the code to complete the mission and you will save the world from obliteration…
Advertisements

Strategic Planning and the Marketing Process
Alabama Primary Health Care Association
Integrating SHE Management Systems in Organizations: A case for Business Sustainability Presentation by A. Chimutanda SHAW 7-9 October 2009.
Advanced Piloting Cruise Plot.
PROCESS SELECTION Chapter 4.
Cost Management ACCOUNTING AND CONTROL
Building a New Payment System: Stakeholder Perspectives on Principles and Elements Robert L. Broadway, FHFMA VP of Corporate Strategy, Bethesda Healthcare.
Chapter 1 The Study of Body Function Image PowerPoint
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
2 Session Objectives Increase participant understanding of effective financial monitoring based upon risk assessments of sub-grantees Increase participant.
ASYCUDA Overview … a summary of the objectives of ASYCUDA implementation projects and features of the software for the Customs computer system.
Business Transaction Management Software for Application Coordination 1 Business Processes and Coordination.
–1–1 State Societies: What Members Need Bruce Kasanoff
Policy development workshop Creating the policy. Objectives - Identify, document and discuss the key steps that typically need to be taken to develop.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Title Subtitle.
My Alphabet Book abcdefghijklm nopqrstuvwxyz.
Multiplying binomials You will have 20 seconds to answer each of the following multiplication problems. If you get hung up, go to the next problem when.
0 - 0.
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
FACTORING ax2 + bx + c Think “unfoil” Work down, Show all steps.
Addition Facts
ZMQS ZMQS
1 Proprietary and confidential. Not to be copied or redistributed without written consent from Medica®. Minnesota Health Action Group February 21, 2013.
Gaining Senior Leadership Support for Continuity of Operations
Presented by the Illinois Department of Insurance Andrew Boron, Director November 2012.
Richmond House, Liverpool (1) 26 th January 2004.
BT Wholesale October Creating your own telephone network WHOLESALE CALLS LINE ASSOCIATED.
Integrated Marketing Communications
1 Dr. Ashraf El-Farghly SECC. 2 Level 3 focus on the organization - Best practices are gathered across the organization. - Processes are tailored depending.
ABC Technology Project
/1 Transparency Challenge Panel March / Welcome & Introductions Suzanne Wise Strategy Consultation Overview of responses and next steps.
2 |SharePoint Saturday New York City
© Charles van Marrewijk, An Introduction to Geographical Economics Brakman, Garretsen, and Van Marrewijk.
VOORBLAD.
SAI Performance Measurement Framework
Squares and Square Root WALK. Solve each problem REVIEW:
© 2012 National Heart Foundation of Australia. Slide 2.
©Ian Sommerville 2004Software Engineering, 7th edition. Chapter 27 Slide 1 Quality Management.
Presented to: Minnesota Chamber of Commerce October 1, 2012.
Chapter 5 Test Review Sections 5-1 through 5-4.
GG Consulting, LLC I-SUITE. Source: TEA SHARS Frequently asked questions 2.
Addition 1’s to 20.
25 seconds left…...
Week 1.
© 2004 Dechert LLP FORM N-CSR, CERTIFICATIONS AND DISCLOSURE CONTROLS AND PROCEDURES James F. DesMarais, Esq. MFS Investment Management Brian S. Vargo,
We will resume in: 25 Minutes.
Module 12 WSP quality assurance tool 1. Module 12 WSP quality assurance tool Session structure Introduction About the tool Using the tool Supporting materials.
McGraw-Hill/Irwin Copyright © 2010 by The McGraw-Hill Companies, Inc. All rights reserved. Global Business and Accounting Chapter 15.
Marketing Channels and Supply Chain Management
PSSA Preparation.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 11 Development Policymaking and the Roles of Market, State, and Civil Society.
1 Chapter 20 New Horizons. 2 Understand the many changing dimensions that shape international business. Learn about and evaluate the international business.
Foundations of Chapter M A R K E T I N G Copyright © 2003 by Nelson, a division of Thomson Canada Limited. Global Marketing 20.
1/16 Service Package for Life Science Start-Ups Regulatory, Reimbursement, Quality and Clinical Research In Europe and the USA UK Office: 27 Old Gloucester.
How Cells Obtain Energy from Food
Immunobiology: The Immune System in Health & Disease Sixth Edition
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress 1 How to Implement a Private Payer Reimbursement Strategy Barbara Grenell.
Stephanie Mensh, M.P.A. Vice President, Reimbursement Policy Lessons Learned From the Mistakes of Others: Reimbursement Issues Harvard Medical Device Congress.
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Presentation transcript:

How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006

A few questions you dont want to hear from your CEO…

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott How can CMS deny coverage for our new technology? FDA has approved it. Should I call Mark McClellan or our member of Congress? A few questions you dont want to hear from your CEO…

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott It is too expensive and time consuming to do a clinical trial. We need to find a way to get CMS to cover this technology based on existing evidence. We can do this, cant we? A few questions you dont want to hear from your CEO…

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott I just spoke with Jack, the CEO of our competitor, Advanced Systems, and he said they got a new CPT code for the neuro device. How come we didnt take the lead on this? What should I tell our customers? A few questions you dont want to hear from your CEO…

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Cant we just let AdvaMed and the big companies carry the weight on reimbursement policy issues? We are too small and cant afford to get engaged. A few questions you dont want to hear from your CEO…

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott It will be hard to increase headcount this year. Do we really need 2 full-time reimbursement staff? Cant we prioritize reimbursement projects? A few questions you dont want to hear from your CEO…

Now, the questions you do want to hear and how to answer them

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Questions you do want to hear Ive been hearing a lot recently about reimbursement. How important is it to our company? Could you provide me with a 101 on how reimbursement works? We have around 15 minutes. What do we need to do to be successful in obtaining reimbursement for our new products?

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Importance of Reimbursement Regulatory approval is insufficient to get a product to market Obtaining reimbursement is a crucial next step Availability of reimbursement has a direct impact on therapy adoption, can make or break a product If a new product is not reimbursed, market will be very restricted at best If providers are not paid adequately, they will be reluctant to provide a new therapy Reimbursement affects market size, not market share

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Importance of Reimbursement Inadequate reimbursement can negatively affect the stock price and availability of venture capital Provide examples of new products in your therapy sector that failed due to lack of reimbursement

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott How Reimbursement Works Each country has its own reimbursement system The US healthcare system involves multiple government and private payers Reimbursement processes differ by payer type Regulatory approval and reimbursement are separate processes

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Reimbursement for New Technologies Three Hurdles Coverage Coding Payment

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Coverage, Coding and Payment Is procedure covered as a benefit? How much will it be paid? No Payment NO YES Step 1 Step 2

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott How Reimbursement Works Solid clinical evidence is required to obtain coverage Demonstrating economic value increasingly important Codes serve to identify new procedures/products, do not guarantee a higher payment Need to demonstrate significant cost increase and clinical/economic value to obtain higher payment Obtaining reimbursement takes a long time, will most likely not be available at launch

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Developing a Successful Reimbursement Program Broad goals and strategies External advocacy Internal processes and programs

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Reimbursement Program Goal Assure adequate reimbursement for new and existing technologies in order to drive therapy adoption

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Reimbursement Strategy Shape government reimbursement policy Pursue adequate reimbursement for specific new technologies Provide customer support

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott External and Internal Strategies Build relationships Pursue advocacy initiatives Obtain stakeholder support Educate key staff Establish processes Integrate reimbursement into product life cycle Develop evidence External Advocacy Internal Capabilities

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott External Advocacy Public and Private Payers Industry Competitors Trade Associations Tech assessment organizations BlueCross/BlueShield TEC Government agencies FDA AHRQ Patients Patent & disease groups Providers Trade associations Physician specialty societies Congress

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Internal Reimbursement Process Establish multi-functional reimbursement team Begin strategy development at R&D stage Integrate reimbursement strategy activities throughout product life cycle

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Reimbursement Integration Continue efforts to obtain codes and higher payment Seek coverage by payers Provide customer support R & D Clinical Trials Regulatory Product Approval Launch Coordinate regulatory and reimbursement strategies Begin implementation of actions to obtain new codes/higher payments Assess clinical/ economic data needs Collect data in trial Provide reimbursement support to trial centers Perform initial reimbursement assessment Reimbursement due diligence Form reimbursement team Develop comprehensive strategy

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Reimbursement Integration Form multi-functional integration team(s) Develop reimbursement SOPs Process Responsibilities

How to Explain Device Reimbursement to Your CEO March 29, © 2006 Abbott Keys to Success Demonstrate clinical and economic value Obtain stakeholder support Internal process integration Adequate staffing and resources Benchmark competitors